0
0
0
Calling for sickle cell trait research, surveillance, and public education and awareness, and for other purposes.
2/5/2024, 2:30 PM
Summary of Bill HRES 672
Bill 118 HRES 672, also known as the "Calling for sickle cell trait research, surveillance, and public education and awareness, and for other purposes" bill, was introduced in the US Congress with the aim of addressing the issues related to sickle cell trait.
The bill calls for increased research on sickle cell trait, a genetic condition that affects the shape of red blood cells and can lead to serious health complications. It also calls for improved surveillance of sickle cell trait in order to better understand its prevalence and impact on individuals.
Additionally, the bill emphasizes the importance of public education and awareness about sickle cell trait, in order to ensure that individuals with the condition are able to access appropriate care and support. Overall, the bill seeks to improve the understanding and management of sickle cell trait in the United States, with the ultimate goal of improving outcomes for individuals affected by this condition.
The bill calls for increased research on sickle cell trait, a genetic condition that affects the shape of red blood cells and can lead to serious health complications. It also calls for improved surveillance of sickle cell trait in order to better understand its prevalence and impact on individuals.
Additionally, the bill emphasizes the importance of public education and awareness about sickle cell trait, in order to ensure that individuals with the condition are able to access appropriate care and support. Overall, the bill seeks to improve the understanding and management of sickle cell trait in the United States, with the ultimate goal of improving outcomes for individuals affected by this condition.
Congressional Summary of HRES 672
This resolution recognizes the challenges posed by sickle cell trait and sickle cell disease and encourages relevant screening, research, and surveillance. Sickle cell disease is a group of inherited disorders that cause abnormally shaped red blood cells.
Read the Full Bill
Current Status of Bill HRES 672
Bill HRES 672 is currently in the status of Bill Introduced since September 8, 2023. Bill HRES 672 was introduced during Congress 118 and was introduced to the House on September 8, 2023. Bill HRES 672's most recent activity was Referred to the House Committee on Energy and Commerce. as of September 8, 2023
Bipartisan Support of Bill HRES 672
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
2Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HRES 672
Primary Policy Focus
HealthAlternate Title(s) of Bill HRES 672
Calling for sickle cell trait research, surveillance, and public education and awareness, and for other purposes.
Calling for sickle cell trait research, surveillance, and public education and awareness, and for other purposes.
Comments
Sponsors and Cosponsors of HRES 672
Latest Bills
REVIEW Act of 2025
Bill HR 6544March 7, 2026
SAVES Act of 2025
Bill S 1441March 7, 2026
A joint resolution providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of the Currency relating to "Rescission of Principles for Climate-Related Financial Risk Management for Large Financial Institutions".
Bill SJRES 113March 7, 2026
Geothermal Cost-Recovery Authority Act of 2025
Bill HR 398March 7, 2026
Geothermal Royalty Reform Act
Bill HR 5638March 7, 2026
Enhancing Geothermal Production on Federal Lands Act
Bill HR 5576March 7, 2026
Iowa National Guard Heroes Commemoration Act
Bill HR 7511March 7, 2026
Geothermal Gold Book Development Act
Bill HR 5617March 7, 2026
Star-Spangled Summit Act of 2025
Bill HR 4684March 7, 2026
BRUSH Fires Act
Bill HR 3553March 7, 2026

